Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVS20 versus carbomer and saline in moderate dry eye syndrome
ISRCTN06098697Phase 2Completed
- Sponsor
- TRB Chemedica
- Start
- Nov 2005
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SVS20 in dry eye syndrome (DED), sponsored by TRB Chemedica. Started Nov 2005; status: completed.
02
Drugs
SVS20
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ISRCTN06098697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN06098697.